A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report

Abstract

Among patients with advanced heart failure, a fully magnetically levitated centrifugal-flow left ventricular assist device was associated with less frequent need for pump replacement than an axial-flow device and was superior with respect to survival free of disabling stroke or reoperation to replace or remove a malfunctioning device. (Funded by Abbott; MOMENTUM 3 ClinicalTrials.gov number, NCT02224755.).

Keywords

Affiliated Institutions

• Brigham and Women's Hospital US
• Harvard University US
• Baptist Health Foundation US
• Yale University US
• Piedmont Atlanta Hospital US
• Methodist Hospital US
• St Vincent Hospital US
• St Thomas' Hospital GB
• Presbyterian Hospital US
• University of Minnesota System US
• University of North Carolina at Chapel Hill US
• University of Nebraska Medical Center US
• New York Hospital Queens US
• Abbott (Sweden) SE
• NewYork–Presbyterian Hospital US
• Duke Medical Center US
• St. Thomas Hospital CA
• Saint Thomas Health US
• University of Chicago Medical Center US
• Columbia University US
• University of Colorado Denver US
• University of Michigan US
• Montefiore Medical Center US
• Albert Einstein College of Medicine US
• MedStar Washington Hospital Center US
• Washington University in St. Louis US
• Advocate Christ Medical Center US

Related Publications